The upside case is a steady but meaningful
rerate, not a moonshot. Cerence already ships at scale, has software-like
gross margins, and needs revenue proof more than technical invention. If it converts recent wins into production, grows
connected services faster than legacy licensing, and uses its balance sheet more efficiently, the stock can plausibly compound at a fast rate from a depressed base. The key is deeper monetization of existing distribution, not dramatic share gains.